Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery

Eur J Anaesthesiol. 2007 Mar;24(3):294-5. doi: 10.1017/S0265021506001657. Epub 2006 Oct 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / therapeutic use*
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Cardiac Surgical Procedures / methods*
  • Drug Interactions
  • Female
  • Follow-Up Studies
  • Heparin / adverse effects
  • Heparin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy*
  • Protein C / adverse effects
  • Protein C / therapeutic use*
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Anticoagulants
  • Protein C
  • Recombinant Proteins
  • Heparin
  • drotrecogin alfa activated